Celebrating Success: Alz Care Ltd Wins Top Pitch at MedTech Investor Gathering

Neil Wright celebrates winning the award alongside colleagues at the Founders Live Cambridge event.

November 6th 2025 marked a significant milestone for Alz Care Ltd as the company secured the winning pitch at a prestigious MedTech investor gathering in Cambridge. This event brought together a carefully selected audience of investors, entrepreneurs and advisors deeply involved in the medical technology and healthcare innovation sectors. The occasion was hosted by Mills and Reeves solicitors with support from Medilink Midlands and TC Group, creating a vibrant platform for emerging MedTech businesses to showcase their innovations.

A Gathering of MedTech Innovators and Experts

The event featured a diverse group of companies presenting groundbreaking ideas and technologies. Among the pitches were an AI chatbot designed to answer medical health questions and a remarkable silicone skin that mimics real human skin for robots. This skin offers lifelike haptic feedback and sensory responses, opening new possibilities in robotics and healthcare applications.

Other presenters included medical practitioners focused on accelerating cancer screening and detection as well as a company developing blood biomarking combined with psychological metrics to identify individuals at risk of self-harm. The room was filled with medical scientists, health technology pioneers and successful entrepreneurs all contributing to a rich exchange of ideas and potential collaborations.

Alz Care Ltd’s Winning Pitch

Alz Care Ltd stood out among the impressive lineup with a compelling presentation that resonated strongly with the audience. The company’s focus on Alzheimer’s research, currently in clinical trials, demonstrated both scientific rigour and clear potential for impact. The pitch highlighted plans to expand beyond Alzheimer’s into a multi-indication therapeutic platform targeting traumatic brain injury (TBI), concussion, post-traumatic stress disorder (PTSD) and neurological rehabilitation.

The audience voted Alz Care Ltd as the winning pitch, recognising the company’s innovative approach and the promise of its therapeutic platform. This achievement not only reflects the strength of the team’s vision but also opens doors to valuable introductions with potential investors and collaborators within the MedTech and healthcare ecosystem.

Building Connections and Opportunities

The event provided more than just a platform for pitching ideas. It fostered meaningful connections between startups, investors and advisors who understand the unique challenges and opportunities in the MedTech space. Thanks to the support from Medilink Midlands, Mills and Reeves solicitors and TC Group, attendees benefited from expert guidance and networking opportunities.

For Alz Care Ltd these connections are crucial as the company prepares to raise £9 million to support its expansion. The funds will accelerate development and clinical trials, enabling the company to bring its therapeutic solutions to a broader range of neurological conditions.

What’s Next for Alz Care Ltd

With the momentum gained from this event, Alz Care Ltd is positioned to advance its research and development efforts. The company aims to:

• Expand its therapeutic platform beyond Alzheimer’s disease

• Target additional neurological conditions such as Traumatic Brain Injury, Concussion, PTSD and neurological rehabilitation

• Secure investment to support clinical trials and product development

• Build partnerships with healthcare providers and research institutions

  
  

This next phase will require strong collaboration and continued innovation. The support from investors and the wider MedTech community will play a vital role in turning these goals into reality.

Final Thoughts

The recent MedTech investor gathering in Cambridge showcased the power of bringing together diverse expertise and innovation in healthcare. Alz Care Ltd’s success at this event highlights the potential for new therapies to address complex neurological conditions and improve patient outcomes.

For those interested in the future of medical technology and healthcare innovation, following Alz Care Ltd’s journey offers insight into how focused research and strategic partnerships can drive progress. The company’s plans to raise £9 million signal a commitment to growth and impact that could benefit many lives.

This event also serves as a reminder of the importance of community and collaboration in advancing medical science. By connecting entrepreneurs, investors, and advisors, gatherings like this create fertile ground for ideas to flourish and transform healthcare.